scholarly article | Q13442814 |
P819 | ADS bibcode | 2012NatCo...3.1044B |
P6179 | Dimensions Publication ID | 1046138584 |
P356 | DOI | 10.1038/NCOMMS2028 |
P932 | PMC publication ID | 3658004 |
P698 | PubMed publication ID | 22948826 |
P5875 | ResearchGate publication ID | 230797734 |
P50 | author | Ulrike Holzgrabe | Q21264805 |
Andreas Bock | Q58898154 | ||
Clelia Dallanoce | Q39931326 | ||
Marco De Amici | Q39931394 | ||
Carlo Matera | Q42870197 | ||
P2093 | author name string | Evi Kostenis | |
Anke Müller | |||
Carsten Hoffmann | |||
Jens Schmitz | |||
Klaus Mohr | |||
Christian Tränkle | |||
Lucas Peters | |||
Nicole Merten | |||
Jessica Klöckner | |||
Ramona Schrage | |||
Julia Bätz | |||
Katharina Simon | |||
Anna Kebig | |||
Jasmin Schrobang-Ley | |||
P2860 | cites work | Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation | Q24303747 |
Structure of a nanobody-stabilized active state of the β(2) adrenoceptor | Q24597139 | ||
Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist | Q24628686 | ||
Crystal structure of the β2 adrenergic receptor-Gs protein complex | Q24635327 | ||
Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor | Q27646733 | ||
Crystal structure of opsin in its G-protein-interacting conformation | Q27652301 | ||
How many drug targets are there? | Q28276660 | ||
Dual effects of muscarinic M(2) acetylcholine receptors on the synthesis of cyclic AMP in CHO cells: dependence on time, receptor density and receptor agonists | Q28360158 | ||
A simple method for quantifying functional selectivity and agonist bias | Q28728741 | ||
Structural diversity of G protein-coupled receptors and significance for drug discovery | Q29616716 | ||
Beta-arrestins and cell signaling | Q29616793 | ||
Diversity of G proteins in signal transduction | Q29618841 | ||
Pathway and mechanism of drug binding to G-protein-coupled receptors. | Q30503489 | ||
Importance of the extracellular loops in G protein-coupled receptors for ligand recognition and receptor activation | Q30522852 | ||
Identification of orthosteric and allosteric site mutations in M2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling bias | Q33748133 | ||
Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery | Q33890786 | ||
Teaching old receptors new tricks: biasing seven-transmembrane receptors | Q33985759 | ||
Molecular basis of ligand dissociation in β-adrenergic receptors | Q34018861 | ||
The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop | Q34504076 | ||
G protein-coupled receptor allosterism and complexing | Q34523552 | ||
Energy landscapes as a tool to integrate GPCR structure, dynamics, and function | Q34664404 | ||
Fluorescent labeling of tetracysteine-tagged proteins in intact cells | Q34913250 | ||
Applying label-free dynamic mass redistribution technology to frame signaling of G protein-coupled receptors noninvasively in living cells. | Q51513968 | ||
Operational models of pharmacological agonism. | Q52699226 | ||
Allosteric Modulation of G Protein–Coupled Receptors | Q56115675 | ||
Convergent, short synthesis of the muscarinic superagonist iperoxo | Q58856252 | ||
Agonist-independent inhibition of G protein activation by muscarinic acetylcholine receptor antagonists in cardiac membranes | Q68033081 | ||
Modification of the binding properties of muscarinic receptors by gallamine | Q71773661 | ||
Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase gamma | Q71970954 | ||
Allosteric interactions with muscarinic acetylcholine receptors: complex role of the conserved tryptophan M2422Trp in a critical cluster of amino acids for baseline affinity, subtype selectivity, and cooperativity | Q83206375 | ||
Principles: extending the utility of [35S]GTP gamma S binding assays | Q35057349 | ||
Scanning mutagenesis studies of the M1 muscarinic acetylcholine receptor | Q35189839 | ||
Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors | Q36773326 | ||
Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors | Q36880900 | ||
The evasive nature of drug efficacy: implications for drug discovery | Q36894549 | ||
Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development | Q36925551 | ||
Heterotrimeric G protein activation by G-protein-coupled receptors | Q37017125 | ||
When simple agonism is not enough: emerging modalities of GPCR ligands. | Q37775132 | ||
The best of both worlds? Bitopic orthosteric/allosteric ligands of g protein-coupled receptors | Q37930665 | ||
A fluorescence resonance energy transfer-based M2 muscarinic receptor sensor reveals rapid kinetics of allosteric modulation | Q39615485 | ||
The C-terminal tail of CRTH2 is a key molecular determinant that constrains Galphai and downstream signaling cascade activation | Q39916587 | ||
Dualsteric GPCR targeting: a novel route to binding and signaling pathway selectivity | Q39931162 | ||
A novel mechanism of G protein-coupled receptor functional selectivity. Muscarinic partial agonist McN-A-343 as a bitopic orthosteric/allosteric ligand. | Q39947679 | ||
Ras-dependent activation of MAP kinase pathway mediated by G-protein beta gamma subunits. | Q41461969 | ||
Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors. | Q42277559 | ||
Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes. | Q42595255 | ||
Deconvolution of complex G protein-coupled receptor signaling in live cells using dynamic mass redistribution measurements. | Q42937057 | ||
Measurement of the millisecond activation switch of G protein-coupled receptors in living cells | Q44479240 | ||
Allosteric site on muscarinic acetylcholine receptors: identification of two amino acids in the muscarinic M2 receptor that account entirely for the M2/M5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-o | Q44483391 | ||
Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors | Q44483424 | ||
Inhibition of the actions of carbachol and DFP on guinea pig isolated atria by alkane-bis-ammonium compounds | Q46165048 | ||
A FlAsH-based FRET approach to determine G protein-coupled receptor activation in living cells | Q46396170 | ||
Critical amino acid residues of the common allosteric site on the M2 muscarinic acetylcholine receptor: more similarities than differences between the structurally divergent agents gallamine and bis(ammonio)alkane-type hexamethylene-bis-[dimethyl-(3 | Q46529162 | ||
Allosteric small molecules unveil a role of an extracellular E2/transmembrane helix 7 junction for G protein-coupled receptor activation | Q46985701 | ||
Functional reconstitution of purified muscarinic receptors and inhibitory guanine nucleotide regulatory protein. | Q48461280 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | transmembrane protein | Q424204 |
P304 | page(s) | 1044 | |
P577 | publication date | 2012-01-01 | |
P1433 | published in | Nature Communications | Q573880 |
P1476 | title | The allosteric vestibule of a seven transmembrane helical receptor controls G-protein coupling | |
P478 | volume | 3 |
Q48136609 | A Photoswitchable Dualsteric Ligand Controlling Receptor Efficacy. |
Q28543750 | A dynamic view of molecular switch behavior at serotonin receptors: implications for functional selectivity |
Q50896283 | A muscarinic view on Gq. |
Q28245604 | A new mechanism of allostery in a G protein-coupled receptor dimer |
Q24308061 | Activation and allosteric modulation of a muscarinic acetylcholine receptor |
Q36342155 | Advances in receptor conformation research: the quest for functionally selective conformations focusing on the β2-adrenoceptor |
Q36836367 | Agonists with supraphysiological efficacy at the muscarinic M2 ACh receptor. |
Q35860717 | Allosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor Mimetics |
Q87410299 | Allostery: A GPCR's back door |
Q55092101 | Binding, Thermodynamics, and Selectivity of a Non-peptide Antagonist to the Melanocortin-4 Receptor. |
Q51266726 | Bitopic muscarinic agonists and antagonists and uses thereof: a patent evaluation of US20160136145A1. |
Q92133857 | Cryptic pocket formation underlies allosteric modulator selectivity at muscarinic GPCRs |
Q33964630 | Decoding signaling and function of the orphan G protein-coupled receptor GPR17 with a small-molecule agonist |
Q60910349 | Designing Hybrids Targeting the Cholinergic System by Modulating the Muscarinic and Nicotinic Receptors: A Concept to Treat Alzheimer's Disease |
Q33922348 | Differences in allosteric communication pipelines in the inactive and active states of a GPCR. |
Q54629048 | Dynamic ligand binding dictates partial agonism at a G protein-coupled receptor. |
Q38211688 | Harnessing allostery: a novel approach to drug discovery |
Q39013350 | Label-free cell-based dynamic mass redistribution assays |
Q41829504 | Ligand Binding Ensembles Determine Graded Agonist Efficacies at a G Protein-coupled Receptor |
Q33577530 | Mapping of allosteric druggable sites in activation-associated conformers of the M2 muscarinic receptor |
Q38066121 | Molecular alliance-from orthosteric and allosteric ligands to dualsteric/bitopic agonists at G protein coupled receptors |
Q38846984 | Multivalent approaches and beyond: novel tools for the investigation of dopamine D2 receptor pharmacology. |
Q38218059 | Muscarinic acetylcholine receptors: novel opportunities for drug development |
Q92534625 | Novel BQCA- and TBPB-Derived M1 Receptor Hybrid Ligands: Orthosteric Carbachol Differentially Regulates Partial Agonism |
Q56001241 | Novel bipharmacophoric inhibitors of the cholinesterases with affinity to the muscarinic receptors M1 and M2 |
Q38631744 | Optical probes based on G protein-coupled receptors - added work or added value? |
Q34249775 | Semisynthetic analogues of toxiferine I and their pharmacological properties at α7 nAChRs, muscle-type nAChRs, and the allosteric binding site of muscarinic M2 receptors |
Q38675922 | Signaling within Allosteric Machines: Signal Transmission Pathways Inside G Protein-Coupled Receptors. |
Q51595080 | Structural Characteristics of the Allosteric Binding Site Represent a Key to Subtype Selective Modulators of Muscarinic Acetylcholine Receptors. |
Q50470980 | Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs. |
Q42001057 | Structure-bias relationships for fenoterol stereoisomers in six molecular and cellular assays at the β2-adrenoceptor. |
Q38567235 | Superagonism at G protein-coupled receptors and beyond |
Q36442376 | The Orphan G Protein-coupled Receptor GPR17 Negatively Regulates Oligodendrocyte Differentiation via Gαi/o and Its Downstream Effector Molecules |
Q90192895 | The Universal 3D QSAR Model for Dopamine D2 Receptor Antagonists |
Q27334167 | The pathway of ligand entry from the membrane bilayer to a lipid G protein-coupled receptor |
Q33613196 | Transmembrane peptides as unique tools to demonstrate the in vivo action of a cross-class GPCR heterocomplex. |
Q33888491 | Tyrosine 308 is necessary for ligand-directed Gs protein-biased signaling of β2-adrenoceptor |
Q92409897 | Utilization of Biased G Protein-Coupled ReceptorSignaling towards Development of Safer andPersonalized Therapeutics |
Search more.